A consensus platform for antibody characterization

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract Antibody-based research applications are critical for biological discovery. Yet, there are no industry standards to compare the performance of antibodies in various applications. We describe a knockout cell line-based antibody characterization platform, developed, and approved jointly by industry and academic researchers that enables the systematic comparison of antibody performance in western blot, immunoprecipitation, and immunofluorescence procedures. The scalable protocols consist of (i) the identification of appropriate cell lines for antibody characterization studies, (ii) development/contribution of isogenic knockout controls, validated at the protein level, and (iii) a series of antibody characterization procedures focused on the most common uses of antibodies in research. Guidelines for the assessment of antibody performance are presented along with the value of making the resulting data publicly available. This antibody characterization platform can be implemented with minimal technological limitations. The proposed antibody characterization platform may be performed readily on antibodies targeting a protein in roughly one month, with one person working less than full-time. Antibody characterization is needed to meet standards for resource validation and data reproducibility, increasingly required by journals and funding agencies.
Full text 5,723 characters · extracted from preprint-html · click to expand
:root { --font-inter: 'Inter', 'Roboto', sans-serif, Symbol; --font-monospace: monospace; --font-roboto: 'Roboto', sans-serif, Symbol; --font-sans-serif: sans-serif; } html, body, div, span, h1, h2, h3, h4, h5, h6, p, ol, ul, li, table, caption, tbody, tfoot, thead, tr, th, td {margin: 0;padding: 0;border: 0;font-size: 100%;font: inherit;vertical-align: baseline;} html {font-size: 14px;line-height: 1.5;} body {font-size: 14px;line-height: 1.5;font-family: var(--font-Roboto);} ol, ul {list-style: none;} blockquote, q {quotes: none;} blockquote:before, blockquote:after, q:before, q:after {content: '';content: none;} img {max-width: 100%;} table {border-collapse: collapse;border-spacing: 0;} b {font-weight: bold;} a {color: #2c71d6;text-decoration: none;} p {margin: 10px 0 10px 0;} .no-select {-o-user-select: none;-moz-user-select: none;-khtml-user-select: none;-webkit-user-select: none;user-select: none;} * {box-sizing: border-box;} @keyframes blink {0% {opacity: .1;}20% {opacity: 1;}100% {opacity: .1;}} .main-preloader{position:fixed;display: flex;top:0;bottom:0;left:0;right:0;align-items: center;justify-content: center;z-index:200000000;text-align:center;background:#F2F3F6;} .main-preloader.dark{background:#363636;} .main-preloader.hidden {display: none;} .main-preloader .mp-logo{height:100px;width:100px;} A consensus platform for antibody characterization V.1 {"@context":"https://schema.org","@id":"https://www.protocols.io/#org","@type":"Organization","logo":{"@type":"ImageObject","height":"1550","url":"https://www.protocols.io/img/protocols-og.jpg","width":"1920"},"name":"protocols.io","url":"https://www.protocols.io/"} {"@context":"https://schema.org","@id":"https://www.protocols.io/#website","@type":"WebSite","name":"protocols.io","publisher":{"@id":"https://www.protocols.io/#org"},"url":"https://www.protocols.io/"} {"@context":"https://schema.org","@id":"https://www.protocols.io/view/strong-a-consensus-platform-for-antibody-characte-14egn9d16l5d/v1#webpage","@type":"WebPage","about":{"@id":"https://www.protocols.io/#org"},"description":"A consensus platform for antibody characterization\n. Antibody-based research applications are critical. Read full protocol, steps, and materials on protocols.io","isPartOf":{"@id":"https://www.protocols.io/#website"},"name":"A consensus platform for antibody characterization\n V.1","url":"https://www.protocols.io/view/strong-a-consensus-platform-for-antibody-characte-14egn9d16l5d/v1"} {"@context":"https://schema.org","@id":"https://www.protocols.io/view/strong-a-consensus-platform-for-antibody-characte-d4f78trn#article","@type":"Article","author":{"@type":"Person","affiliation":"Dev","name":"Protocols Importer"},"dateModified":"2024-04-11T07:27:16Z","datePublished":"2024-04-11T07:27:16Z","description":"A consensus platform for antibody characterization\n. Antibody-based research applications are critical. Read full protocol, steps, and materials on protocols.io","headline":"A consensus platform for antibody characterization\n V.1","image":{"@type":"ImageObject","url":"https://files.protocols.io/webapp/images/q2ckeg/meta/protocolsio.png"},"mainEntityOfPage":{"@id":"https://www.protocols.io/view/strong-a-consensus-platform-for-antibody-characte-d4f78trn#webpage"},"publisher":{"@id":"https://www.protocols.io/#org"}} var WebappBundlePath = "https:\/\/files.protocols.io\/webapp\/bundles\/production-7c378af\/"; var AMPLITUDE_API_KEY="c250ed1d862cb9c01587e1f779a32c9";var FFMPEG_HOST="https://ffmpeg.protocols.io";var FILES_CDN_URL="https://files.protocols.io";var FILES_S3_BUCKET="protocols-io-files";var FILES_S3_PREFIX="external";var GA_MEASUREMENT_ID="G-33ZGV5CT0B";var GOOGLE_CLIENT_ID="182746271041-rdtjk0b1h9706r0fgpq1o2h55lgbo8un.apps.googleusercontent.com";var HAS_SSR= false ;var HOST_ROLE= 1 ;var HOST_ROLES={"HOST_DEV":2,"HOST_LOCAL":3,"HOST_PROD":1};var IMAGE_BASE_PATH="https://files.protocols.io/webapp/images/q2ckeg/";var NATS_SERVER="wss://ws.protocols.io";var ORCID_CLIENT_ID="APP-7405TP4958GFSZXV";var ORCID_URL="https://orcid.org/oauth/authorize";var RECAPTCHA_SITE_ID="6LeMF6YUAAAAAOYzOqfc9Ml3PdTgIzO1oDdIwCYc";var SITE_URL="https://www.protocols.io";var SPRINGERNATURE_CLIENT_ID="protocolsio";var SPRINGERNATURE_REDIRECT="https://www.protocols.io/api/v1/auth/springernature/authcallback";var SPRINGERNATURE_URL="https://idp.springernature.com";var STRIPE_PUB_KEY="pk_live_51PfMxdRshFFmaQRVGeDsSX7NFFLMkMuqr17SxP6JcJuieglmQYHPgM7cz0XdO91IEVP9k4E4MC7PZB2ATyuuaOy800ivYpRURi";var UIPE="wc05D1v3cmNUzSbgJrtE4b2Tmq8MTTxeLA31r0RcNxA=";var VPC_ALLOW_REGENTS_LINKING= false ;var VPC_DISABLED_INVITE_COLLEAGUES= false ;var VPC_DISABLED_PUBLISHING= false ;var VPC_DISABLED_SIGN_UP= false ;var VPC_DISABLED_WORKSPACE_CREATION= false ;var VPC_EXTERNAL_STORAGES= null ;var VPC_FORWARDED_VIEW_URL_PREFIX="";var VPC_MAIN_CLOUD_URL="https://www.protocols.io";var VPC_REQUIRE_SIGN_IN= false ;var VPC_USE_MAIN_GLOBAL_SEARCH= false ;var WEBAPP_VERSION="production-7c378af";var __stripeGlobal= null ;var cookie_session_guid="7BF150335AFB11F1A33B0A58A9FEAC02";var gosessid="7BF14E925AFB11F1A33B0A58A9FEAC02";var is_premium= false ;var loadedAmplitude= false ;var loadedGA= false ;var logged_in= false ;var session_guid="";var show_loader= true ;var user_theme="default"; var is_grecaptcha_loaded = false; if (!Element.prototype.matches) Element.prototype.matches = Element.prototype.msMatchesSelector; if (!Element.prototype.closest) Element.prototype.closest = function (selector) {var el = this; while (el) {if (el.matches(selector)) return el; el = el.parentElement;}}; .noscript-container { margin: 0 auto; width: 400px; text-align: center; margin-top: 150px; } protocols.io requires JavaScript to be enabled in the browser.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0